SecBot SecBot
SECBOTREPLAY Home › Report › IOVA

IOVA · Iovance Biotherapeutics granted inducement stock options covering…

Iovance Biotherapeutics, Inc. · PRESS-RELEASE filed Apr 17, 2026 at 17:15 ET

At the news

NEUTRALIMPACT 2/10

PRESS-RELEASE filed Apr 17, 2026 at 17:15 ET

Iovance Biotherapeutics granted inducement stock options covering 135,470 shares to twelve new non-executive employees, priced at $3.80 per share with three-year vesting. This is a routine hiring incentive and does not reflect a material strategic or financial change.

  • Iovance granted stock options for 135,470 shares to twelve new non-executive employees.
  • Options were granted under the 2021 Inducement Plan, compliant with Nasdaq Rule 5635(c)(4).
  • Exercise price is $3.80, equal to the closing price on the grant date (April 16, 2026).
  • Vesting: one-third on first anniversary, remainder over eight quarterly installments thereafter.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access